Protocol ID
GOG 0258
Protocol Description
A randomized phase III trial of cisplatin and tumor volume directed irradiation by carboplatin and paclitaxel vs. carboplatin and paclitaxel for optimally debulked, advanced, endometrial carcinoma: GOG-0258
Description
This study will compare the effects of two treatments in patients with endometrial cancer contained in the abdomen as well as collect samples of your tumor tissue and blood to help create special tests to determine which patients may respond to and have a better prognosis to certain treatments. The investigational treatment consists of Cisplatin given together with radiation therapy followed by the drugs Carboplatin and Paclitaxel for four cycles. Another treatment, which is the current standard therapy, consists of Carboplatin and Paclitaxel given for six cycles without radiation therapy.
The participant and/or their insurance provider will be responsible for the costs of medical care given while in the study.
Eligibility Criteria
In general, this study is looking for participants who:
- Have stage III or IVA endometrial cancer OR stage I and II clear cell of serous papillary uterine cancer with positive cytology.
Primary Investigator(s)
Dennis R. Scribner, Jr., M.D.
Contact Information
Sarah Henderson, Research Administrator
Carilion GYN Oncology
540-981-8169
sehenderson@carilionclinic.org
for mail
for deliveries